Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients

NCT05410951 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT05410951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05410951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Active, not recruiting
Start date
May 16, 2022
Completion date
May 16, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, lobular breast carcinoma, lobular in situ breast carcinoma